AI tutor takes on lupus nephritis: could chatbots teach doctors better?

NCT ID NCT07706998

Not yet recruiting Knowledge-focused Sponsor: Nanjing University Source: ClinicalTrials.gov ↗

First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This trial tests an AI-powered teaching platform called iLN, which uses a large language model to help medical students learn about lupus nephritis. Fifty fourth-year medical students are randomly assigned to either use iLN or attend a traditional PowerPoint lecture. The study measures learning through test scores and student feedback to see if the AI platform improves understanding and engagement.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: an AI-powered interactive teaching platform called iLN
What this could lead to: If successful, this could show that AI-based teaching tools improve medical education, potentially leading to better-trained doctors.
What could go wrong: This is a small, early-stage study in 50 students at one university, so results may not apply broadly. The platform's effectiveness depends on student engagement and may not outperform traditional methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LEARNING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

learning disability lupus nephritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LEARNING

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Nanjing university

Nanjing, Jiangsu, 210016, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.